Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anh Nguyen Lien Phan"'
Autor:
Anh Nguyen Lien Phan, Thuy Thi Thanh Pham, Xinh Thi Phan, Nghia Huynh, Tuan Minh Nguyen, Cuc Tran Thu Cao, Duong Thuy Nguyen, Khanh Thi Xuan Luong, Tam Thi Minh Nguyen, Anh Ngoc Kim Tran, Linh Thi Truc Pham, Vy Vuong Thao Nguyen, Sigrid Swagemakers, Chi‐Bao Bui, Petrus Martinus Van Hagen
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 9, Iss 8, Pp n/a-n/a (2021)
Abstract Background X‐linked hyper‐IgM syndrome (XHIGM) is a rare primary immunodeficiency caused by CD40 ligand defects. Methods We identified three patients with XHIGM in Ho Chi Minh City, Vietnam. Whole‐exome sequencing, immunological analys
Externí odkaz:
https://doaj.org/article/0ec76ae80e114e07ab80a8c6c31d35d3
Autor:
Linh Thi Truc Pham, Xinh Thi Phan, Thuy Thi Thanh Pham, Vy Nguyen, Tuan Minh Nguyen, Anh Tran, Anh Nguyen Lien Phan, Sigrid M. A. Swagemakers, Petrus Martinus van Hagen, Khanh Thi Xuan Luong, Nghia Huynh, Tam Thi Minh Nguyen, Chi-Bao Bui, Cuc Tran Thu Cao, Duong Thuy Nguyen
Publikováno v:
Molecular Genetics & Genomic Medicine
Molecular Genetics and Genomic Medicine, 9(8):e1732. John Wiley & Sons Inc.
Molecular Genetics & Genomic Medicine, Vol 9, Iss 8, Pp n/a-n/a (2021)
Molecular Genetics and Genomic Medicine, 9(8):e1732. John Wiley & Sons Inc.
Molecular Genetics & Genomic Medicine, Vol 9, Iss 8, Pp n/a-n/a (2021)
Background X‐linked hyper‐IgM syndrome (XHIGM) is a rare primary immunodeficiency caused by CD40 ligand defects. Methods We identified three patients with XHIGM in Ho Chi Minh City, Vietnam. Whole‐exome sequencing, immunological analyses and we
Autor:
Nghia Huynh, Anh Nguyen Lien Phan, Chi-Bao Bui, Thuy Thanh T Pham, Cuc Tran Thu Cao, Duc T. Le, Duong Thuy Nguyen, Tuan M. Nguyen
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 8, Iss 5, Pp n/a-n/a (2020)
Molecular Genetics & Genomic Medicine
Molecular Genetics & Genomic Medicine
Background Lipopolysaccharide‐responsive and beige‐like anchor (LRBA) deficiency is a rare autosomal recessive common variable immunodeficiency (CVID), affecting 1:25,000–1:50,000 people worldwide. Biallelic mutations in the gene LRBA have been